Travere Therapeutics Inc (TVTX)
Healthcare
Biotechnology
55.00 $
-1.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Travere Therapeutics Inc (TVTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -40 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -69 | -59 | -70 | -119 | -40 | -43 | -36 | -42 | 5.0 | 14 | 61 | -40 | 40 | |
| 14 | 11 | 12 | 9.9 | 10 | 11 | 12 | 13 | 14 | 16 | 18 | 25 | 73 | |
| 12 | 11 | 8.1 | 9.8 | 9.9 | 8.0 | 9.2 | 11 | 11 | 11 | 11 | 16 | 50 | |
| 11 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -6.9 | -3.6 | 7.1 | -2.9 | -61 | -6.7 | 7.4 | -24 | -5.6 | -37 | 53 | -45 | -35 | |
| 3.2 | 0.0 | 5.5 | 6.5 | 12 | 8.2 | 9.6 | 12 | 0.2 | 0.1 | 19 | 22 | 41 | |
| -24 | 133 | -17 | 105 | 29 | 46 | -80 | 41 | 4.9 | 87 | -105 | 22 | 8.2 | |
| 3.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 0.0 | – | – | |
| 2.3 | -0.6 | 0.1 | -0.5 | 0.8 | 0.0 | 139 | 3.7 | 1.5 | -65 | 27 | 4.2 | -33 | |
| -91 | 73 | -86 | -15 | -11 | 4.1 | 22 | 3.4 | 13 | 36 | -18 | -15 | 16 | |
| -73 | -59 | -76 | -125 | -52 | -51 | -45 | -54 | 4.7 | 14 | 42 | -63 | -1.8 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.